Hodgson DC, Brierley JD, Tsang RW, Panzarella T. Prescribing 131Iodine based on neck uptake produces effective thyriod ablation and reduced hospital stay. // Radiother Oncol; 1998 47 (3) :325-30
Hurley J.R. Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131) I scan-negative patients. // Endocr Pract; 2000 6 (5) :401-6
Ikekubo K. Hino M., Ito H., et al. The early detection of metastases differentiated thyriod cancer using 131-I total body scan and treatment with 131I. // Kaku Igaku; 1991 28 (3) :247-59
Jochansen K, Woodhoyse N.J., Odugbesan O. Comparison of 1073 and 3700 MBq MBq iodini-131 in postoperative ablation of residual thyriod tissue in patients with differentiated thyriod cancer. // J Nucl Med; 1991 32 (2) :352-4
Kao C.H, Yen T, C. Stunning effects after a diagnostic dose of iodine-131. // Nuklearmedizin; 1998 37 (1) :30-2
Kasagi K., Miyamoto S., Endo K., et al. Increased uptake of ioidine-131 in metastases od differentiated thyriod carcinoma associated with less severe hypothyroidism following total thyroidectomy. // Cancer; 1993 72 (6) :1983-90
Khan JH, McElhinney DB, Rahman S, B., et al. Pulmonary metastases of endocrine origin: the role of surgery. // Chest; 1998 114 (2) :526-34
Kim J.H., Kim E.S., Lee J.V. Radiation dosimetry of in vivo and in vitro irradiation of iodine-131. // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.82
Kitazono M., Robey R., Zhan Z., et al. Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na (+)/I (-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. // J Clin Endocrinol Metab; 2001 86 (7) :3430-5
Koerber C., Schmutzler C., Rendl J., et al. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid. // Clin Nucl Med 1999 24 (11) :849-851
Koong S.S., Reynjlds J.C., Movius E.D., et al. Lithyum as a potentional adjuvant to 131I therapy of metastatic well differentiated thyriod carcinoma. // J Clin Endocrinol Met; 1999 84 (3) :912-6
Krausz Y. Nuclear endocrinology as a monitoring tool.// Semin Nucl Med; 2001 31 (3) :238-50
Krishnamurthy G.T., Blahd W.H. Radioiodine I-131 therapy in the management of thyriod cance. A prospective study. // Cancer; 1977 40 (1) :195-202
Kuriakose M.A., Hicks W.L., Loree T.R., et al. Risk group-based management of differentiated thyroid carcinoma. // J R Coll Surg Edinb; 2001 46 (4) :216-23
Ladenson P.W., Ewertz M.E., Dickey R.A. Practical application of recombinant thyrotropin testing in clinical practice. // Endocr Pract; 2001 7 (3) :195-201
Leger A.F. Distant metastasis of differentiated thyroid cancers. Diagnosis by 131 iodine (I 131) and treatment. // Ann Endocrinol (Paris); 1995 56 (...
